Contact Information

Insurance Information

Guarantor Mailing Address


Additional Information

SaVida Treatment Policies

The success of your treatment and recovery is dependent on your adherence to our treatment program and
our policies. You are expected to:


  • Be on time for appointments. Part of recovery is being able to be accountable. If you must cancel, provide 24 hours-notice so we may fill your appointment slot.

  • Notify SaVida Health of any change in address or phone number.

  • Do not arrive at the office intoxicated or under the influence of drugs. If you are intoxicated, we may not be able to provide your buprenorphine/naloxone prescription that day.

  • Keep all medications in a safe place. SaVida is not responsible to replace lost/stolen medication.

  • Do not share your medication. This may result in the person’s overdose or death. Immediately call 911 for assistance, even if there are no obvious signs of distress.

  • Bring your buprenorphine bottle, blister-packs, or films/wrappers (both opened/unopened) to each visit, in the appropriate labeled container. We want to ensure you are responsibly taking of your meds.

  • Do not tamper with any urine drug screens. It is important for us to understand where you are in your recovery of if there has been a relapse. This will enable us to provide you with the best possible care.

  • Take your medicine as instructed. If your urine doesn’t show that buprenorphine is present, or if the buprenorphine/norbuprenorphine levels are negative or below the expected levels, you may be required to come to the office for Observed Dosing.

  • Come into the office when contacted to do so. We may ask you to come into the office for an unplanned (random) drug screen to ensure you are in recovery.

  • Inform SaVida Health of any new medications or medical conditions, and any adverse effects you experience from the medications you take. There are very rare drug interactions, but it is important that ALL your providers are aware of whatever medications you are taking.

  • Inform SaVida Health of any upcoming surgeries or dental work so that SaVida may coordinate planning with your other treatment providers. This should be done before pain medication prescriptions are filled at a pharmacy. It may not be safe to take buprenorphine/naloxone and pain medication simultaneously, and the pain medication should be used with caution. If a doctor or dentist gives you a pain medication prescription, you do not need to fill it. When there are significant pain issues and medication is necessary, SaVida will try to coordinate care with the provider to understand how buprenorphine/naloxone works and what your needs are.

  • Inform SaVida of any vacations or trips prior to leaving the area. Proof of the trip will be requested.

  • Do not eat foods containing poppy seeds while in treatment These may impact your UDS test results.

  • Agree to participate in counseling, as appropriate. Counseling in combination with medication has proven to be the most effective treatment for substance use disorder.

What To Expect

While everyone’s treatment plan is individualized, a typical treatment plan includes the following phases:

Induction Phase

  • Intake/Initial Appointment: history, physical exam, lab draw (blood draw), urine drug test/alcohol screen, meeting with a medical provider

  • Induction Appointment: 1- 3 days after initial intake; some patients may qualify for a home induction but may still be required to have one day of observed dosing in the office to ensure proper use.

  • Medication and Symptom Evaluation: 5-7 days after induction.

  • Behavioral and Case Management Appointment(s)

Stabilization Phase (weekly appointments):

  • Minimum Time in Phase: 8-12 weeks; except for transfer patients

  • Typical Criteria for Next Phase (biweekly):

    • 8 consecutive urine drug screens negative for substances of abuse

    • 8 counseling/case management sessions

    • able to maintain safety/security of prescription (i.e. not lost/stolen)

    • able to routinely keep all scheduled appointments

    • able to maintain stable/safe housing

  • During this phase you will have weekly visits. You may need to come in more frequently than weekly depending on your progress.

Maintenance Phase (biweekly or monthly appointments):

  • Once stabilized, patients may move from weekly to bi-weekly and then to monthly.

  • Improvements in markers of recovery: e.g. resolved legal issues, verified employment, disability status, enrolled student status, appropriate custodial parenting dictate how quickly a patient can be moved to monthly.

  • Counseling/case management sessions as recommended but no less than quarterly.

  • Each patient receives a Semi-Annual Treatment Plan Review (every 6 months). This is a more complex visit involving your entire treatment team: prescriber or regular medical provider, case management, and review with behavioral health collaboration team member (as applicable).

You should not take any other medications without first discussing with your healthcare provider.



Buprenorphine is an FDA approved medication for treatment of people with opioid use disorder.

You can become dependent on buprenorphine/naloxone. Buprenorphine treatment does result in physical dependence—
meaning you will need to take it to feel well and not be in withdrawal. If buprenorphine is suddenly discontinued, patients
may have symptoms such as muscle aches, stomach cramps, or diarrhea lasting several days. To minimize the possibility
of withdrawal symptoms, tapering and discontinuation should be a slow process and close monitoring is recommended.
Buprenorphine tapering generally occurs over several months.

If you are dependent on opioids, you must be in withdrawal when you take the first dose of buprenorphine. If you are not
in withdrawal, buprenorphine can cause severe opioid withdrawal symptoms.

It may take several days to get used to the transition from the opioid previously used to buprenorphine. During this time, any use of other opioids may cause an increase in symptoms.

After becoming stabilized on buprenorphine, the use of other opioid will have less effect. Attempts to override the buprenorphine by taking more opioids could result in an opioid overdose and can be fatal.

Combining buprenorphine with alcohol or other medications may be hazardous. Combining buprenorphine with benzodiazepine medications such as Xanax, Klonopin, Valium, Haldol, Librium and Ativan can be dangerous without proper medical supervision.

Buprenorphine tablets or film must be held under the tongue until they completely dissolve; buprenorphine will not be absorbed from the stomach if it is swallowed intact. Injecting your medication can cause a number of medical complications and can be hazardous. Like all opioids, patients may suffer side effects such as constipation, dry mouth,
nausea, and headache.

I hereby authorize and give voluntary consent to SaVida Health and its medical personnel to prescribe buprenorphine as part of the treatment for my opiate dependence. I understand there are potential risks and benefits. Treatment procedures have been explained to me, and I understand that this will involve my taking buprenorphine at the schedule determined by my medical provider in accordance with Federal and State regulations. I understand that I my leave the program at any time with or without a supervised tapering of my buprenorphine dose.




My signature below indicates that:

  1. I agree to be tested for HIV

  2. I have been given information about the test.

  3. All of my questions about the test have been answered.

  4. I understand that this consent will expire one year from the date it is signed. I understand I may withdraw my consent at any time.

  5. My decision to be tested is completely voluntary.

HIV Testing Consent Signatures



My signature below indicates that:

  1. I agree to be tested for Hepatitis C.

  2. I have been given information about the test.

  3. All of my questions about the test have been answered.

  4. I understand that this consent will expire one year from the date it is signed. I understand I may withdraw my consent at any time.

  5. My decision to be tested is completely voluntary.

Hepatitis C Testing Consent Signatures



Supplemental Questionnaire

When did your dependence start?

What day and time did you last use?

When did you last take methadone (date/time)?

Female Patients Only



I authorize SaVida Health staff to receive my medical history.


I understand that I may withdraw this consent at any time, either verbally or in writing except to the extent that action has been taken in reliance on it. This consent will last while I am being treated for opioid dependence by the physician specified above, unless I withdraw my consent during treatment. This consent will expire 365 days after I complete my treatment, unless the physician specified above is otherwise notified by me

I understand that the records to be released may contain information pertaining to psychiatric treatment and/or treatment for alcohol and/or drug dependence. These records may also contain confidential information about communicable diseases including HIV (AIDS) or related illness. I understand that these records are protected by the Code of Federal Regulations Title 42 Part 2 (42 CFR Part 2) which prohibits the recipient of these records from making any further disclosures to third parties without the express written consent of the patient. I acknowledge that I have been notified of my rights pertaining to the confidentiality of my treatment information/records under 42 CFR Part 2, and I further acknowledge that I understand those rights.